Clinical trials

  • ELACESTRANT for Hormone receptor positive HER2-negative early breast cancer
  • 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H- 1,2,4-TRIAZOL-3-AMINE for Active pulmonary sarcoidosis
  • RISANKIZUMAB for Juvenile psoriatic arthritis
  • SURABGENE LOMPARVOVEC for Neovascular age-related macular degeneration
  • 3-FLUORO-5-{[(2AR,4S)-1,1,2,2,4-PENTAFLUORO-2A-HYDROXY-2,2A,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN-5-YL]OXY}BENZONITRILE for Advanced liver cancer | Hepatocellular carcinoma (HCC)
  • POVORCITINIB for Vitiligo
  • ZANUBRUTINIB for Cold agglutinin disease
  • TACROLIMUS for Liver transplantation
  • MESENCHYMAL STROMAL CELLS, EX VIVO CULTURED for Steroid-refractory acute graft-versus-host disease|Acute graft-versus-host disease
  • RADIPRODIL for Tuberous sclerosis complex | Focal cortical dysplasia Type II
  • JNJ-78278343 for Metastatic castration-resistant prostate cancer
  • OCRELIZUMAB for Primary progressive multiple sclerosis